1887
Letter Open Access
Like 0
Preview this article:

There is no abstract available.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2024.29.19.2400236
2024-05-09
2024-11-08
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2024.29.19.2400236
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/29/19/eurosurv-29-19_4.html?itemId=/content/10.2807/1560-7917.ES.2024.29.19.2400236&mimeType=html&fmt=ahah

References

  1. Klitting R, Piorkowski G, Rousset D, Cabié A, Frumence E, Lagrave A, et al. Molecular epidemiology identifies the expansion of the DENV2 epidemic lineage from the French Caribbean Islands to French Guiana and mainland France, 2023 to 2024. Euro Surveill. 2024;29(13):2400123.  https://doi.org/10.2807/1560-7917.ES.2024.29.13.2400123  PMID: 38551097 
  2. Jakhar K, Sonar S, Singh G, Sarkar T, Tiwari M, Kaur J, et al. SARS-CoV-2 antibodies cross-react and enhance dengue infection. Preprint. bioRxiv. 2023; 2023.10.09.557914 . https://doi.org/10.1101/2023.10.09.557914 
  3. Teo A, Tan HD, Loy T, Chia PY, Chua CLL. Understanding antibody-dependent enhancement in dengue: Are afucosylated IgG1s a concern? PLoS Pathog. 2023;19(3):e1011223.  https://doi.org/10.1371/journal.ppat.1011223  PMID: 36996026 
  4. Thomas S, Smatti MK, Ouhtit A, Cyprian FS, Almaslamani MA, Thani AA, et al. Antibody-Dependent Enhancement (ADE) and the role of complement system in disease pathogenesis. Mol Immunol. 2022;152:172-82.  https://doi.org/10.1016/j.molimm.2022.11.010  PMID: 36371813 
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error